Karen J. Greenberg
Karen J. Greenberg, a noted expert on national security, terrorism, and civil liberties, is Director of the Center on National Security. She is the author of The Least Worst Place: Guantanamo’s First 100 Days (Oxford University Press, 2009), which was selected as one of the best books of 2009 by The Washington Post and Slate.com. […]
Charles Davi
Charles is a capital market and derivatives market lawyer at a large firm in New York City, an author for The Atlantic and a member of the Board of Concord 51 PAC. Charles represents large financial institutions, asset managers and insurance companies in a wide variety of capital market and derivatives market transactions, ranging from […]
Mara M. Burr
Mara M. Burr is the Deputy Assistant United States Trade Representative (DAUSTR) for South and Central Asian Affairs where she has responsibilities for all trade and economic issues with the South and Central Asian countries of Afghanistan, Pakistan, India, Bangladesh, Sri Lanka, Nepal, Bhutan, Kazakhstan, Kyrgyzstan, Turkmenistan, Tajikistan, Uzbekistan, Maldives and the U.S. trade relationship […]
Laurie Garrett
Laurie Garrett is the senior fellow for global health at the Council on Foreign Relations. She is the only writer to have been awarded all three of the big “Ps” of journalism: the Peabody, the Polk, and the Pulitzer. Garrett is also the best-selling author of The Coming Plague: Newly Emerging Diseases in a World […]
Dr. Emilio Emini
Emilio A. Emini, Ph.D., is Senior Vice President and Chief Scientific Officer of Vaccine Research at Pfizer Inc., a position into which he transitioned subsequent to Pfizer’s acquisition of Wyeth Pharmaceuticals in late 2009. Dr. Emini joined Wyeth as Executive Vice President of Vaccine Research and Development in November 2005. At Wyeth, he led the […]
Dr. George Poste
Dr. George Poste is Chief Scientist, Complex Adaptive Systems Initiative (CASI), Regents’ Professor and Del E. Webb Chair in Health Innovation at Arizona State University. He assumed this post in February 2009. This program links expertise across the university in research on synthetic biology, ubiquitous sensing and healthcare informatics for personalized medicine. He founded the Biodesign Institute […]
Dr. Eric Rose
Eric A. Rose, M.D. was elected Chairman of the Board of Directors in January 2007 and became the Company’s Chief Executive Officer in March 2007. Dr. Rose has served as a director of SIGA since April 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001. In April 2008, Dr. Rose assumed […]
Amb. Nancy G. Brinker
Nancy G. Brinker is a three-time Ambassador and New York Times best-selling author who is regarded as the leader of the global breast cancer movement. Her journey began with a promise to her dying sister, Susan G. Komen, that she would do everything possible to end the shame, pain, fear, and hopelessness caused by this […]
Congressman Mac Thornberry
Rep. Mac Thornberry (R-TX) currently serves as the Vice Chairman of the House Armed Services Committee where he leads the Subcommittee on Emerging Threats. He is also a member of the House Permanent Select Committee on Intelligence. In early 2011, Mac was appointed by House leaders to spearhead a Cybersecurity Task Force to guide action […]
Lynn Forester De Rothschild
Since June 2002, Lady de Rothschild has been the Chief Executive of E.L. Rothschild LLC, a private investment company with investments in media, information technology, agriculture and real estate worldwide. Holdings include The Economist Group (UK), Weather Central LP (US), real estate and financial instruments. Lady de Rothschild has been a director of The Estee […]
Dr. Margaret A. Hamburg
Margaret A. Hamburg, M.D. is the 21st Commissioner of the U.S. Food and Drug Administration. As the top official at the FDA, Dr. Hamburg is committed to strengthening programs and policies that enable the agency to carry out its fundamental mission — to protect and promote the public health. Only the second woman ever to serve […]